Lonza Group AG

Lonza Group AG is a leading contract development and manufacturing organization specializing in the healthcare sector. The company partners with a diverse clientele, ranging from emerging biotechnology firms to established global pharmaceutical companies, to facilitate the advancement of novel therapies. Lonza Group AG offers a comprehensive suite of services including early-stage drug development, active pharmaceutical ingredient manufacturing, cell and gene therapy capabilities, and oral drug product development. Its business is structured across three synergistic platforms: Integrated Biologics, Advanced Synthesis, and Specialized Modalities, enabling support for both established and cutting-edge technologies such as mammalian biologics, mRNA, bioconjugates, and microbial production. Headquartered in Basel, Switzerland, and operating across more than 30 sites globally, Lonza Group AG plays a pivotal role in the life sciences value chain by supporting its customers from preclinical research through commercial manufacturing, ultimately helping to deliver life-saving and life-enhancing treatments to patients worldwide.